EHA 2023 | Goals and work of the EAHAD gene therapy working group
Michiel Coppens, MD, PhD, Amsterdam UMC, Amsterdam, The Netherlands, talks about the European Association for Haemophilia and Allied Disorders (EAHAD) gene therapy working group, highlighting their focus on accessibility to gene therapies. Dr Coppens also describes the ‘hub and spoke’ model for implementing gene therapies, which EAHAD promotes alongside producing educational material regarding gene therapies. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Grant/research support: Anthos, Bayer, CSL Behring/UniQure, Novo Nordisk, Roche
Lecturing/consultancy: Alexion, CSL Behring, Daiichi Sankyo, Sobi, Viatris
Member EAHAD Gene Therapy working group, ERN-EuroBloodNet
